CRVSCorvus Pharmaceuticals, Inc.

$14.74

Is it safe?

Can CRVS take a bad year?

The deepest fall in CRVS's price history on file is −97%; it is −42% below its high today.

−97%

Worst drawdown on file · −42% today

Cash runway
4.8 years

Cash runway · burning $11M a quarter at the current rate

Annualised volatility
142%

Annualised volatility · three times the market's own swing

Details
Cash and short-term investments
$215M
EBITDA, trailing twelve months
−$57M
Operating profit, trailing twelve months
−$57M
Annualised volatilitytwo years of daily moves
142%
Worst drawdown on file
−97%
Below its 52-week high
−42%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.